James W. Huleatt

Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen

Stephanie C. Eisenbarth, Damani A. Piggott, James W. Huleatt et al. · The Journal of Experimental Medicine · 2002 · 1.2K citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +22

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

James W. Huleatt, Valerian Nakaar, Priyanka Desai et al. · Vaccine · 2007 · 385 citations

Vaccination, Cross-protection, Vaccine Development +10

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

James W. Huleatt, Andrea R. Jacobs, Jie Tang et al. · Vaccine · 2006 · 293 citations

Vaccination, Toll-like Receptors, Cross-protection +12

MyD88-dependent induction of allergic Th2 responses to intranasal antigen

Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu et al. · Journal of Clinical Investigation · 2005 · 211 citations · Full text

MyD88-dependent induction of allergic Th2 responses to intranasal antigen

Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu et al. · Journal of Clinical Investigation · 2005 · 203 citations · Full text

Lung Inflammation, Allergy Medicine, Innate Immune System +24